表紙
市場調査レポート

免疫化学分析装置と検査キット:世界的なパイプライン分析、競合状況、2018年までの市場将来予測

Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

発行 GlobalData 商品コード 239480
出版日 ページ情報 英文 137 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
免疫化学分析装置と検査キット:世界的なパイプライン分析、競合状況、2018年までの市場将来予測 Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
出版日: 2012年04月25日 ページ情報: 英文 137 Pages
概要

当レポートでは、世界の免疫化学市場を国別/部門別に分析し、2004-2011年間の収益データと2018年までの将来予測、及び2011年の企業シェアデータを提供し、主な市場トレンド/発展・阻害要因をカテゴリ別に分析し、さらに主要市場プレーヤ/競合状況/主要パイプライン製品と技術についての情報も盛り込み、概略下記の構成でお届けいたします。

第1章 目次

第2章 イントロダクション

第3章 免疫化学の概要

  • 免疫化学市場の分化

第4章 世界市場の特性化

  • 世界的過去収益 (2004-2011)
  • 世界的予測収益 (2011-2018)
  • 主要トレンド
  • 市場動態

第5章 部門別分析

  • 貧血/ビタミン検査市場:世界的過去収益 (2004-2011)
  • 貧血/ビタミン検査市場:世界的予測収益 (2011-2018)
  • 貧血/ビタミン検査市場:市場動態
  • 疾患特異的免疫化学市場:世界的過去収益 (2004-2011)
  • 疾患特異的免疫化学市場:世界的予測収益 (2011-2018)
  • 疾患特異的免疫化学市場:市場動態
  • 乱用薬物/毒物市場:世界的過去収益 (2004-2011)
  • 乱用薬物/毒物市場:世界的予測収益 (2011-2018)
  • 乱用薬物/毒物市場:市場動態
  • 薬物治療モニタリング市場:世界的過去収益 (2004-2011)
  • 薬物治療モニタリング市場:世界的予測収益 (2011-2018)
  • 薬物治療モニタリング市場:市場動態
  • 内分泌検査市場:世界的過去収益 (2004-2011)
  • 内分泌検査市場:世界的予測収益 (2011-2018)
  • 内分泌検査市場:市場動態
  • 免疫化学分析装置市場:世界的過去収益 (2004-2011)
  • 免疫化学分析装置市場:世界的予測収益 (2011-2018)
  • 免疫化学分析装置市場:市場動態
  • 免疫化学迅速検査市場:世界的過去収益 (2004-2011)
  • 免疫化学迅速検査市場:世界的予測収益 (2011-2018)
  • 免疫化学迅速検査市場:市場動態
  • 臓器機能試験市場:世界的過去収益 (2004-2011)
  • 臓器機能試験市場:世界的予測収益 (2011-2018)
  • 臓器機能試験市場:市場動態
  • 特異蛋白質市場:世界的過去収益 (2004-2011)
  • 特異蛋白質市場:世界的予測収益 (2011-2018)
  • 特異蛋白質市場:市場動態

第6章 国別収益分析:2004-2018

  • 米国の過去収益 (2004-2011)
  • 米国の予測収益 (2011-2018)
  • カナダの過去収益 (2004-2011)
  • カナダの予測収益 (2011-2018)
  • 英国の過去収益 (2004-2011)
  • 英国の予測収益 (2011-2018)
  • ドイツの過去収益 (2004-2011)
  • ドイツの予測収益 (2011-2018)
  • フランスの過去収益 (2004-2011)
  • フランスの予測収益 (2011-2018)
  • イタリアの過去収益 (2004-2011)
  • イタリアの予測収益 (2011-2018)
  • スペインの過去収益 (2004-2011)
  • スペインの予測収益 (2011-2018)
  • 日本の過去収益 (2004-2011)
  • 日本の予測収益 (2011-2018)
  • 中国の過去収益 (2004-2011)
  • 中国の予測収益 (2011-2018)
  • インドの過去収益 (2004-2011)
  • インドの予測収益 (2011-2018)
  • オーストラリアの過去収益 (2004-2011)
  • オーストラリアの予測収益 (2011-2018)
  • ブラジルの過去収益 (2004-2011)
  • ブラジルの予測収益 (2011-2018)

第7章 戦略的競合評価

  • 主要市場参入企業

第8章 戦略的パイプライン評価

第9章 戦略的取引分析

  • 取引状況の特徴である多数の提携
  • PE/VC企業からの投資が免疫化学市場の革新を促進
  • 主要取引

第10章 付録

図表

目次
Product Code: GDME0145MAR

Summary

GlobalData's new report, "Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global immunochemistry market. The report provides market landscape, competitive landscape and market trends information on the immunochemistry market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Key segments covered include Anemia/ Vitamin Tests, Disease Specific Immunochemistry, Drugs of Abuse/Toxicology, Therapeutic Drug Monitoring, Endocrinology Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests, Organ Function Assays and Specific Proteins.
  • Annualized market revenues data from 2004 to 2011, forecast forward for seven years to 2018, and company shares data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints within clinical chemistry market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare and Abbott Laboratories.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the immunochemistry globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify the key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What's the next big thing in the immunochemistry market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global immunochemistry market and the factors shaping it.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Immunochemistry Overview

  • 3.1. Immunochemistry, Market Segmentation
    • 3.1.1. Anemia/Vitamin Tests
    • 3.1.2. Disease Specific Immunochemistry
    • 3.1.3. Drugs of Abuse/Toxicology
    • 3.1.4. Therapeutic Drug Monitoring (TDM)
    • 3.1.5. Endocrinology Tests
    • 3.1.6. Immunochemistry Analyzers
    • 3.1.7. Immunochemistry Rapid Tests
    • 3.1.8. Organ Function Assays
    • 3.1.9. Specific Proteins

4. Immunochemistry-Global Market Characterization

  • 4.1. Immunochemistry Market, Global, Revenue ($m), Historic, 2004-2011
  • 4.2. Immunochemistry Market, Global, Revenue ($m), Forecast, 2011-2018
  • 4.3. Immunochemistry Market, Key Trends
    • 4.3.1. Improvement in Software, Hardware Technology and User Interface to Improve Immunochemistry Analyzers Adoption Rate
    • 4.3.2. Advent of Home Based Testing Methods to Lead to Increase in Demand for Diagnostic Testing
    • 4.3.3. Point of Care Testing (POCT) to be in High Demand but Adoption will Depend on Technological Developments in this Field
  • 4.4. Immunochemistry, Market Dynamics
    • 4.4.1. Market Drivers
    • 4.4.2. Market Restraints

5. Global Immunochemistry Market-Analysis by Segment

  • 5.1. Anemia/ Vitamin Test Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.2. Anemia/ Vitamin Test Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.3. Anemia/ Vitamin Test Market, Market Dynamics
    • 5.3.1. Market Drivers
    • 5.3.2. Market Restraint
  • 5.4. Disease Specific Immunochemistry Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.5. Disease Specific Immunochemistry Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.6. Disease Specific Immunochemistry, Market Dynamics
    • 5.6.1. Market Drivers
    • 5.6.2. Market Restraints
  • 5.7. Drugs of Abuse/Toxicology Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.8. Drugs of Abuse/Toxicology Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.9. Drugs of Abuse/Toxicology, Market Dynamics
    • 5.9.1. Market Drivers
    • 5.9.2. Market Restraints
  • 5.10. Therapeutic Drug Monitoring Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.11. Therapeutic Drug Monitoring Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.12. Therapeutic Drug Monitoring, Market Dynamics
    • 5.12.1. Market Driver
    • 5.12.2. Market Restraint
  • 5.13. Endocrinology Tests Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.14. Endocrinology Tests Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.15. Endocrinology Tests, Market Dynamics
    • 5.15.1. Market Driver
    • 5.15.2. Market Restraint
  • 5.16. Immunochemistry Analyzers Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.17. Immunochemistry Analyzers Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.18. Immunochemistry Analyzers, Market Dynamics
    • 5.18.1. Market Driver
    • 5.18.2. Market Restraint
  • 5.19. Immunochemistry Rapid Tests Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.20. Immunochemistry Rapid Tests Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.21. Immunochemistry Rapid Tests, Market Dynamics
    • 5.21.1. Market Driver
    • 5.21.2. Market Restraint
  • 5.22. Organ Function Assays Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.23. Organ Function Assays Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.24. Organ Function Assays, Market Dynamics
    • 5.24.1. Market Driver
    • 5.24.2. Market Restraint
  • 5.25. Specific Proteins Market, Global, Revenue ($m), Historic, 2004-2011
  • 5.26. Specific Proteins Market, Global, Revenue ($m), Forecast, 2011-2018
  • 5.27. Specific Proteins, Market Dynamics
    • 5.27.1. Market Driver
    • 5.27.2. Market Restraint

6. Immunochemistry Market, Analysis by Country, Revenue ($m), 2004-2018

  • 6.1. Immunochemistry Market, the US, Revenue ($m), Historic, 2004-2011
  • 6.2. Immunochemistry Market, the US, Revenue ($m), Forecast, 2011-2018
  • 6.3. Immunochemistry Market, Canada, Revenue ($m), Historic, 2004-2011
  • 6.4. Immunochemistry Market, Canada, Revenue ($m), Forecast, 2011-2018
  • 6.5. Immunochemistry Market, the UK, Revenue ($m), Historic, 2004-2011
  • 6.6. Immunochemistry Market, the UK, Revenue ($m), Forecast, 2011-2018
  • 6.7. Immunochemistry Market, Germany, Revenue ($m), Historic, 2004-2011
  • 6.8. Immunochemistry Market, Germany, Revenue ($m), Forecast, 2011-2018
  • 6.9. Immunochemistry Market, France, Revenue ($m), Historic, 2004-2011
  • 6.10. Immunochemistry Market, France, Revenue ($m), Forecast, 2011-2018
  • 6.11. Immunochemistry Market, Italy, Revenue ($m), Historic, 2004-2011
  • 6.12. Immunochemistry Market, Italy, Revenue ($m), Forecast, 2011-2018
  • 6.13. Immunochemistry Market, Spain, Revenue ($m), Historic, 2004-2011
  • 6.14. Immunochemistry Market, Spain, Revenue ($m), Forecast, 2011-2018
  • 6.15. Immunochemistry Market, Japan, Revenue ($m), Historic, 2004-2011
  • 6.16. Immunochemistry Market, Japan, Revenue ($m), Forecast, 2011-2018
  • 6.17. Immunochemistry Market, China, Revenue ($m), Historic, 2004-2011
  • 6.18. Immunochemistry Market, China, Revenue ($m), Forecast, 2011-2018
  • 6.19. Immunochemistry Market, India, Revenue ($m), Historic, 2004-2011
  • 6.20. Immunochemistry Market, India, Revenue ($m), Forecast, 2011-2018
  • 6.21. Immunochemistry Market, Australia, Revenue ($m), Historic, 2004-2011
  • 6.22. Immunochemistry Market, Australia, Revenue ($m), Forecast, 2011-2018
  • 6.23. Immunochemistry Market, Brazil, Revenue ($m), Historic, 2004-2011
  • 6.24. Immunochemistry Market, Brazil, Revenue ($m), Forecast, 2011-2018

7. Immunochemistry Market-Strategic Competitive Assessment

  • 7.1. Immunochemistry, Key Market Participants
    • 7.1.1. Siemens Healthcare Inc.
    • 7.1.2. F. Hoffmann-La Roche Ltd.
    • 7.1.3. Abbott Laboratories

8. Immunochemistry-Strategic Pipeline Assessment

9. Immunochemistry Market-Strategic Deals Analysis

  • 9.1. High Number of Partnerships Characterizing the Deal Landscape
  • 9.2. Investments by PE/VC Firms to Spur Innovation in Immunochemistry Market
  • 9.3. Key Deals
    • 9.3.1. Ventana Medical Enters into a Number of Companion Diagnostics Partnerships with Multiple Partners
    • 9.3.2. Dako Enters into Co-development Agreement with Amgen
    • 9.3.3. Sigma-Aldrich Completes Acquisition of BioReliance for $350m
    • 9.3.4. Pronota Raises $4.8m in Series C Financing
    • 9.3.5. Roche Enters into Joint Venture Agreement with Swiss Federal Institute of Technology, University of Zurich and University Hospital Zurich
    • 9.3.6. Affymetrix to acquire eBioscience for $330m

10. Appendix

  • 10.1. Market Definitions
    • 10.1.1. Immunochemistry
  • 10.2. Acronyms
  • 10.3. Research Methodology
    • 10.3.1. Secondary Research
    • 10.3.2. Primary Research
    • 10.3.3. Models
    • 10.3.4. Forecasts
    • 10.3.5. Expert Panels
    • 10.3.6. GlobalData Consulting
    • 10.3.7. Contact Us
    • 10.3.8. Disclaimer
  • 10.4. Sources
    • 10.4.1. Corporate, Industry and Government Sources
    • 10.4.2. Journals
    • 10.4.3. Online Publications
    • 10.4.4. Press Releases

List of Tables

  • Table 1: Immunochemistry Market, Global, Revenue ($m), 2004 - 2011
  • Table 2: Immunochemistry Market, Global, Revenue ($m), 2011 - 2018
  • Table 3: Companion Diagnostics in Immunochemistry
  • Table 4: Roche, Number of Companion Diagnostic Projects, 2006-2010
  • Table 5: Companion Diagnostics, Value Proposition Analysis
  • Table 6: Companion Diagnostics, Number of Partnerships, 2004-2010
  • Table 7: Number of Corporate Diagnostic Laboratory Chains, India, 2010
  • Table 8: Comparison of Various Finance Options
  • Table 9: Laboratory Acquisitions, the US, 2002-2008
  • Table 10: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2004 - 2011
  • Table 11: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2011 - 2018
  • Table 12: Percentage of Factors Contributing to Anemia Prevalence
  • Table 13: Correlation of Anemia and Economic Conditions
  • Table 14: Vitamin D Diagnosis, Product Approvals, 1999-2011
  • Table 15: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2004 - 2011
  • Table 16: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2011 - 2018
  • Table 17: Newly Discovered Tumor Markers, 2008-2011
  • Table 18: Principle of Action, Tumor Markers
  • Table 19: Prevalence Rate of Various Allergies, the US, 2001-2010
  • Table 20: Prevalence of Respiratory Symptoms and Risk Factors Among Children Aged between 6-11 Years, the UK, 2007-2008
  • Table 21: Prevalence of Autoimmune Diseases, Global, 2010
  • Table 22: Autoimmune Disease Research Funding, the US, 2005-2011
  • Table 23: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2004 - 2011
  • Table 24: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2011 - 2018
  • Table 25: Past Month* Illicit Drug Usage among Persons Aged 12 and Older, 2010
  • Table 26: Past Month* Usage of Selected Illicit Drugs among Persons Aged 12 or Older, 2002-2010
  • Table 27: Past Month* Illicit Drug Use among Persons Aged 12 or Older (%), by Age, 2009 - 2010
  • Table 28: Drug Tests, Olympics (Summer and Winter), 2000-2010
  • Table 29: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2004 - 2011
  • Table 30: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2011 - 2018
  • Table 31: Number of Public Hospitals with Internet Access, Ecuador, 2008-2010
  • Table 32: Endocrinology Tests Market, Global, Revenue ($m), 2004 - 2011
  • Table 33: Endocrinology Tests Market, Global, Revenue ($m), 2011 - 2018
  • Table 34: Immunochemistry Analyzers Market, Global, Revenue ($m), 2004 - 2011
  • Table 35: Immunochemistry Analyzers Market, Global, Revenue ($m), 2011 - 2018
  • Table 36: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011
  • Table 37: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018
  • Table 38: Use of Immunoassay Detection Test, by Diagnosed Disease
  • Table 39: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011
  • Table 40: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018
  • Table 41: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011
  • Table 42: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018
  • Table 43: Immunochemistry Market, the US, Revenue ($m), 2004-2011
  • Table 44: Immunochemistry Market, the US, Revenue ($m), 2011-2018
  • Table 45: Immunochemistry Market, Canada, Revenue($m), 2004-2011
  • Table 46: Immunochemistry Market, Canada, Revenue ($m), 2011-2018
  • Table 47: Immunochemistry Market, the UK, Revenue ($m), 2004-2011
  • Table 48: Immunochemistry Market, the UK, Revenue ($'000), 2011-2018
  • Table 49: Immunochemistry Market, Germany, Revenue ($m), 2004-2011
  • Table 50: Immunochemistry Market, Germany, Revenue ($m), 2011-2018
  • Table 51: Immunochemistry Market, France, Revenue ($m), 2004-2011
  • Table 52: Immunochemistry Market, France, Revenue ($m), 2011-2018
  • Table 53: Immunochemistry Market, Italy, Revenue ($m), 2004-2011
  • Table 54: Immunochemistry Market, Italy, Revenue ($m), 2011-2018
  • Table 55: Immunochemistry Market, Spain, Revenue ($), 2004-2011
  • Table 56: Immunochemistry Market, Spain, Revenue ($m), 2011-2018
  • Table 57: Immunochemistry Market, Japan, Revenue ($m), 2004-2011
  • Table 58: Immunochemistry Market, Japan, Revenue ($'000), 2011-2018
  • Table 59: Immunochemistry Market, China, Revenue ($m), 2004-2011
  • Table 60: Immunochemistry Market, China, Revenue ($m), 2011-2018
  • Table 61: Immunochemistry Market, India, Revenue ($m), 2004-2011
  • Table 62: Immunochemistry Market, India, Revenue ($m), 2011-2018
  • Table 63: Immunochemistry Market, Australia, Revenue ($m), 2004-2011
  • Table 64: Immunochemistry Market, Australia, Revenue ($m), 2011-2018
  • Table 65: Immunochemistry Market, Brazil, Revenue ($m), 2004-2011
  • Table 66: Immunochemistry Market, Brazil, Revenue ($m), 2011-2018
  • Table 67: Immunochemistry Market, Global, Company Share (%), 2011
  • Table 68: Siemens Healthcare, Immunochemistry Portfolio*, 2011
  • Table 69: Siemens Healthcare, Immunochemistry Pipeline Portfolio, by Segment
  • Table 70: Siemens Healthcare, Emerging Markets Growth, 2008-2010
  • Table 71: F. Hoffmann-La Roche Ltd., Immunochemistry Portfolio*, 2011
  • Table 72: F. Hoffmann-La Roche Ltd., Immunochemistry Pipeline Portfolio, by Segment
  • Table 73: F. Hoffmann-La Roche Ltd., Number of Companion Diagnostic Projects, 2006-2010
  • Table 74: Abbott Laboratories, Immunochemistry Portfolio*, 2011
  • Table 75: Abbott Laboratories, Immunochemistry Pipeline Portfolio, by Segment
  • Table 76: Immunochemistry, Global Pipeline Products, 2011
  • Table 77: Immunochemistry, Global Pipeline Distribution, by Market Segments, 2011
  • Table 78: Immunochemistry Market, Deals, 2009-2011

List of Figures

  • Figure 1: Immunochemistry, Market Segmentation
  • Figure 2: Disease Specific Immunochemistry, Market Segmentation
  • Figure 3: Drugs of Abuse/Toxicology, Market Segmentation
  • Figure 4: Therapeutic Drug Monitoring, Market Segmentation
  • Figure 5: Endocrinology Tests, Market Segmentation
  • Figure 6: Immunochemistry Analyzers, Market Segmentation
  • Figure 7: Immunochemistry Market, Global, Revenue ($m), 2004 - 2011
  • Figure 8: Immunochemistry Market, Global, Revenue ($m), 2011 - 2018
  • Figure 9: Immunochemistry, Market Dynamics
  • Figure 10: Roche, Number of Companion Diagnostic Projects, 2006-2010
  • Figure 11: Companion Diagnostics, Value Proposition Analysis
  • Figure 12: Companion Diagnostics, Number of Partnerships, 2004-2010
  • Figure 13: Hub and Spoke Model used by Diagnostic Laboratories
  • Figure 14: Laboratory Acquisitions, the US, 2002-2008
  • Figure 15: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2004 - 2011
  • Figure 16: Anemia/ Vitamin Test Market, Global, Revenue ($m), 2011 - 2018
  • Figure 17: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2004 - 2011
  • Figure 18: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2011 - 2018
  • Figure 19: Autoimmune Disease Research Funding, the US, 2005-2011
  • Figure 20: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2004 - 2011
  • Figure 21: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2011 - 2018
  • Figure 22: Past Month* Illicit Drug Usage among Persons Aged 12 and Older, 2010
  • Figure 23: Past Month* Usage of Selected Illicit Drugs among Persons Aged 12 or Older, 2002-2010
  • Figure 24: Past Month* Illicit Drug Use among Persons Aged 12 or Older (%), by Age, 2009 - 2010
  • Figure 25: Drug Tests, Olympics (Summer and Winter), 2000-2010
  • Figure 26: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2004 - 2011
  • Figure 27: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2011 - 2018
  • Figure 28: Number of Public Hospitals with Internet Access, Ecuador, 2008-2010
  • Figure 29: Endocrinology Tests Market, Global, Revenue ($m), 2004 - 2011
  • Figure 30: Endocrinology Tests Market, Global, Revenue ($m), 2011 - 2018
  • Figure 31: Immunochemistry Analyzers Market, Global, Revenue ($m), 2004 - 2011
  • Figure 32: Immunochemistry Analyzers Market, Global, Revenue ($m), 2011 - 2018
  • Figure 33: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011
  • Figure 34: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018
  • Figure 35: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011
  • Figure 36: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018
  • Figure 37: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2004 - 2011
  • Figure 38: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2011 - 2018
  • Figure 39: Immunochemistry Market, the US, Revenue ($m), 2004-2011
  • Figure 40: Immunochemistry Market, the US, Revenue ($m), 2011-2018
  • Figure 41: Immunochemistry Market, Canada, Revenue($m), 2004-2011
  • Figure 42: Immunochemistry Market, Canada, Revenue ($m), 2011-2018
  • Figure 43: Immunochemistry Market, the UK, Revenue ($m), 2004-2011
  • Figure 44: Immunochemistry Market, the UK, Revenue ($m), 2011-2018
  • Figure 45: Immunochemistry Market, Germany, Revenue ($m), 2004-2011
  • Figure 46: Immunochemistry Market, Germany, Revenue ($m), 2011-2018
  • Figure 47: Immunochemistry Market, France, Revenue ($m), 2004-2011
  • Figure 48: Immunochemistry Market, France, Revenue ($m), 2011-2018
  • Figure 49: Immunochemistry Market, Italy, Revenue ($m), 2004-2011
  • Figure 50: Immunochemistry Market, Italy, Revenue ($m), 2011-2018
  • Figure 51: Immunochemistry Market, Spain, Revenue ($m), 2004-2011
  • Figure 52: Immunochemistry Market, Spain, Revenue ($m), 2011-2018
  • Figure 53: Immunochemistry Market, Japan, Revenue ($m), 2004-2011
  • Figure 54: Immunochemistry Market, Japan, Revenue ($m), 2011-2018
  • Figure 55: Immunochemistry Market, China, Revenue ($m), 2004-2011
  • Figure 56: Immunochemistry Market, China, Revenue ($m), 2011-2018
  • Figure 57: Immunochemistry Market, India, Revenue ($m), 2004-2011
  • Figure 58: Immunochemistry Market, India, Revenue ($m), 2011-2018
  • Figure 59: Immunochemistry Market, Australia, Revenue ($m), 2004-2011
  • Figure 60: Immunochemistry Market, Australia, Revenue ($m), 2011-2018
  • Figure 61: Immunochemistry Market, Brazil, Revenue ($m), 2004-2011
  • Figure 62: Immunochemistry Market, Brazil, Revenue ($m), 2011-2018
  • Figure 63: Immunochemistry Market, Global, Company Share (%), 2011
  • Figure 64: Siemens Healthcare, Immunochemistry Pipeline Portfolio, by Segment
  • Figure 65: Siemens Healthcare, SWOT Analysis, 2011
  • Figure 66: Siemens Healthcare, Revenue Share, by Region, 2010
  • Figure 67: Siemens Healthcare, Emerging Markets Growth, 2008-2010
  • Figure 68: F. Hoffmann-La Roche Ltd., Immunochemistry Pipeline Portfolio, by Segment
  • Figure 69: F. Hoffmann-La Roche Ltd., SWOT Analysis, 2011
  • Figure 70: F. Hoffmann-La Roche Ltd., Number of Companion Diagnostic Projects, 2006-2010
  • Figure 71: Abbott Laboratories, Immunochemistry Pipeline Portfolio, by Segment
  • Figure 72: Abbott Laboratories, SWOT Analysis, 2011
  • Figure 73: Immunochemistry, Global Pipeline Products, 2011
  • Figure 74: Immunochemistry, Global Pipeline Distribution, by Market Segments, 2011
  • Figure 75: Immunochemistry Market, Deals, 2009-2011
Back to Top